Comprehensive analysis of Bank of India Large & Mid Cap Fund - Reg (IDCW-Q) (9073) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
Bank of India Investment Managers Private Ltd
The Scheme seeks to generate income and long-term capital appreciation by investing through a diversified portfolio of predominantly large cap and mid cap equity and equity related securities including equity derivatives. The Scheme is in the nature of large and mid cap fund. The Scheme is not providing any assured or guaranteed returns
A comprehensive at-a-glance view of key mutual fund health indicatorsHover or click any card to view detailed metrics
Weak Returns
High Risk
High Expenses
Equity Focused
Experienced Team
Below Average
Showing 1Y NAV history
Performance across different time periods
Fund shows concerning indicators. Exercise caution before investing.
Consider waiting for better market conditions or explore alternatives.
Fund shows concerning indicators. Exercise caution before investing.
Consider waiting for better market conditions or explore alternatives.
Fund manager experience
Market exposure level
Historical performance consistency
Recent performance momentum
Outperformance vs benchmark
Risk-adjusted returns
Assets under management
Fund management costs
This fund has outperformed its benchmark by 1.14% over the 3Y period.
See how your money can grow and compare with popular investment options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
| Company | Sector | % Assets |
|---|---|---|
| HDFC Bank Ltd | Banks | 8.00% |
| TREPS | Debt Others | 5.37% |
| Reliance Industries Ltd | Refineries | 4.39% |
| Lloyds Metals & Energy Ltd | Mining & Mineral products | 3.74% |
| ICICI Lombard General Insurance Company Ltd | Insurance | 3.46% |
| Larsen & Toubro Ltd | Infrastructure Developers & Operators | 3.30% |
| PB Fintech Ltd | IT - Software | 3.20% |
| Kotak Mahindra Bank Ltd | Banks | 3.01% |
| ERIS Lifesciences Ltd | Pharmaceuticals | 2.98% |
| Indian Bank | Banks | 2.94% |
Compare against Large & Mid Cap Fund category average
This comparison shows how the fund performs relative to the Large & Mid Cap Fund category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Large & Mid Cap Fund category
| Fund Name | NAV | 6M | 1Y | 3Y |
|---|---|---|---|---|
| Nippon India Vision Large & Mid Cap Fund - Dir (G) | ₹1569.51 | 16.72% | 0.82% | 20.98% |
| Nippon India Vision Large & Mid Cap Fund - (G) | ₹1458.74 | 16.37% | 0.25% | 20.35% |
| ICICI Pru Large & Mid Cap Fund - Direct (G) | ₹1116.27 | 15.33% | 1.24% | 22.12% |
| ICICI Pru Large & Mid Cap Fund - (G) | ₹998.01 | 14.82% | 0.36% | 21.05% |
| Aditya Birla SL Large & Mid Cap Fund - Dir (G) | ₹994.35 | 17.65% | -3.72% | 14.37% |
| Aditya Birla SL Large & Mid Cap Fund (G) | ₹893.12 | 17.18% | -4.48% | 13.45% |
| DSP Large & Mid Cap Fund - Direct (G) | ₹675.68 | 13.77% | -4.00% | 20.49% |
| SBI Large & Midcap Fund - Direct (G) | ₹673.64 | 15.58% | 2.17% | 18.27% |
| SBI Large & Midcap Fund (G) | ₹620.27 | 15.09% | 1.29% | 17.24% |
| DSP Large & Mid Cap Fund - Regular (G) | ₹604.04 | 13.18% | -4.98% | 19.31% |
A seasoned investment professional with over 17 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.